StockData
iRhythm Holdings, Inc. logo

iRhythm Holdings, Inc. (IRTC) company profile

IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/303% below fair value
$89.67−1.16 (-1.28%)

Close on Nov 17, 2026Market cap $2.96BP/E –Yield –

About iRhythm

Surgical & Medical Instruments & Apparatus, SIC 3841

iRhythm is a digital healthcare company providing device-based technology for ambulatory cardiac monitoring. Its offerings combine wearable, patch-based biosensors with cloud-based data analytic software to monitor patients and assist in diagnosing arrhythmias, such as atrial fibrillation. Key systems include the Zio monitor, Zio XT, and Zio AT systems, which support long-term continuous monitoring and mobile cardiac telemetry services. Customers and users primarily comprise physicians, cardiology practices, electrophysiologists, primary care clinicians, integrated delivery networks, and value-based healthcare organizations.

Headquartered in San Francisco, California, the company maintains independent diagnostic testing facilities in the United States and directly markets services domestically. Internationally, the company operates in the United Kingdom, Japan, and several European nations including Switzerland, Austria, the Netherlands, and Spain, utilizing direct sales teams and third-party distribution partners. As of late 2025, the company employed approximately 2,400 regular full-time employees and had processed over twelve million patient reports.

Summary of the business section of iRhythm's latest annual report, written by StockData.

Company profile

Company

Legal name
iRhythm Holdings, Inc.
Founded
2006
Headquarters
San Francisco, CA
Address
699 8th Street, Suite 600 94103
Phone
(415) 632-5700
Employees
2,400, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, San Jose, California

Stock & identifiers

Ticker
IRTC
Exchange
Nasdaq
IPO date
Oct 20, 2016
Shares outstanding
33M, Jul 30, 2026
Public float
$4.90B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1388658
CUSIP
450056106
ISIN
US4500561067
FIGI
BBG001J19V24
Share class FIGI
BBG001TSQV70
LEI
549300FJI72RJGDQS384
EIN
41-3421287

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Quentin S. BlackfordPresident and CEO, Director226,008
Daniel G. WilsonChief Financial Officer34,987
Sumi ShrishrimalEVP, Chief Risk Officer44,621
Minang TurakhiaCHIEF MED/SCI OFCR EVP ADVTECH60,116
Chad PattersonCHIEF COMM & PRODUCT OFFICER62,125
Patrick Michael MurphyCBO and CLO69,699
Mervin SmithEVP Strategic Business Ops22,410
Julianne RoddaEVP, CHIEF PEOPLE OFFICER18,201
Sean Clinton FreemanEVP, Strategy & Corp Devt13,641
Marc Wade RosenbaumChief Accounting Officer16,155
Brian Lee LawrenceChief Technology Officer20,154
Karen K. McGinnisDirector3,608
Abhijit Y. TalwalkarDirector21,872
Brian B. YoorDirector7,171
Bruce G. BodakenDirector14,211
Merz Cathleen Noel BaireyDirector10,546
Karen LingDirector11,141
Kevin C. OboyleDirector3,608
Jason H. PattenDirector4,436
Ralph SnydermanDirector13,288
Mark J. RubashDirector13,788

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$11.00M$45.12M$3.45M$75$79
FY2024$9.34M$1.29M$3.05M$38$79
FY2023$16.60M$16.26M$5.42M$45$75
FY2022$7.97M$5.27M$4.42M$39$79
FY2021
Douglas Devine
$5.70M$2.90M$3.36M$50$104
FY2021
Kevin King
$30.71K-$9.81M$3.36M$50$104

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
Quentin Blackford
President and Chief Executive Officer
$700.00K$8.92M$1.35M$33.70K$11.00M+18%
Daniel Wilson
Chief Financial Officer
$446.16K$2.07M$490.50K$33.54K$3.04M+20%
Patrick Murphy
Chief Business Officer and Chief Legal Officer
$468.65K$2.07M$486.50K$32.20K$3.06M+2%
Chad Patterson
Chief Commercial Officer
$495.96K$2.80M$750.00K$33.45K$4.08M+12%
Minang (Mintu) Turakhia, M.D., M.S.
Chief Medical and Scientific Officer, and EVP, Advanced Technologies
$478.59K$2.59M$523.20K$31.30K$3.63M+9%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Oct 20, 2016
Offer price
$17.00
Securities offered
6,294,118
Gross proceeds
$107.00M
Exchange
Nasdaq
First trading day
Oct 20, 2016
First-day close
$26.05+53.2%
Lock-up ends (est.)
Apr 18, 2017

“Per Share Total Initial Public Offering Price $ 17.00 $ 107,000,006 Underwriting Discounts and Commissions (1) $ 1.19 $ 7,490,000 Proceeds to iRhythm Technologies, Inc.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 2,400 employees globally.”

Corporate history

Events identified from SEC filings

DateEventDetails
Apr 1, 2026Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 30, 2026DeregistrationTermination of SEC registration (Form 15)
Jan 12, 2026Name changeName changed from iRhythm Technologies, Inc. to iRhythm Holdings, Inc.
Nov 19, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Nov 13, 2019Late filingNotification of late filing
Jul 31, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 4, 2019Late filingNotification of late filing
Oct 20, 2016IPOInitial public offering priced (424B4 prospectus)
Oct 13, 2016ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?